Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Febuxostat, sold under the brand name Uloric among others, is a medication used long-term to treat gout due to high uric acid levels. It is generally recommended only for people who cannot take allopurinol. It is taken by mouth.
History & Applications
Explore the main themes, entities and connections around Febuxostat. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
allopurinol drug xanthine acid oxidase effects uric recommended use approved side teijin heart-related people increased risk death compared 2009 include
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Febuxostat | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Febuxostat | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Febuxostat | ATC code | M04AA03 (WHO) | 1.00 | infobox |
| Febuxostat | Bioavailability | ≥84% absorbed | 1.00 | infobox |
| Febuxostat | CAS Number | 144060-53-7 N | 1.00 | infobox |
| Febuxostat | ChEBI | CHEBI:31596 | 1.00 | infobox |
| Febuxostat | ChEMBL | ChEMBL1164729 Y | 1.00 | infobox |
| Febuxostat | ChemSpider | 118173 Y | 1.00 | infobox |
| Febuxostat | CompTox Dashboard (EPA) | DTXSID8048650 | 1.00 | infobox |
| Febuxostat | DrugBank | DB04854 N | 1.00 | infobox |
| Febuxostat | ECHA InfoCard | 100.207.329 | 1.00 | infobox |
| Febuxostat | Elimination half-life | ~5–8 hours | 1.00 | infobox |
| Febuxostat | Excretion | Urine (~49%, mostly as metabolites, 3% as unchanged drug); feces (~45%, mostly as metabolites, 12% as unchanged drug) | 1.00 | infobox |
| Febuxostat | Formula | C16H16N2O3S | 1.00 | infobox |
| Febuxostat | IUPHAR/BPS | 6817 | 1.00 | infobox |
| Febuxostat | KEGG | D01206 Y | 1.00 | infobox |
| Febuxostat | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Febuxostat | Legal status | US: ℞-only | 1.00 | infobox |
| Febuxostat | Legal status | EU: Rx-only | 1.00 | infobox |
| Febuxostat | License data | US DailyMed: Febuxostat | 1.00 | infobox |
| Febuxostat | MedlinePlus | a609020 | 1.00 | infobox |
| Febuxostat | Metabolism | via CYP1A1, 1A2, 2C8, 2C9, UGT1A1, 1A8, 1A9 | 1.00 | infobox |
| Febuxostat | Molar mass | 316.38 g·mol−1 | 1.00 | infobox |
| Febuxostat | Pregnancy category | AU: B1 | 1.00 | infobox |
| Febuxostat | Protein binding | 99.2% to albumin | 1.00 | infobox |
| Febuxostat | PubChem CID | 134018 | 1.00 | infobox |
| Febuxostat | Routes of administration | By mouth | 1.00 | infobox |
| Febuxostat | Trade names | Uloric, Adenuric, others | 1.00 | infobox |
| Febuxostat | UNII | 101V0R1N2E | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.